Anti-inflammatory pharmaceutical products
View Patent ↗Polypeptides having homology to regions of the N-terminal 50 residues of human Annexin 1 are provided for medical use as anti-inflammatory agents. Some of the polypeptides have homology to the N-terminal 48 residues of human Annexin 1, especially to residues 2-48 and 11-48 thereof. In some embodiments, properties of these compounds are improved by at least one modification at residues corresponding to residues 11, 22, 25 and/or 36 of human Annexin 1, and/or by C-terminal amidation of the polypeptide. Analogs of amino acids 2-26 of human Annexin 1, especially acetylated at the N-terminus and/or amidated at the C-terminus and having modifications at 11 and/or 22 are also disclosed for medical use as anti-inflammatory agents.
1. An isolated polypeptide comprising the amino acid sequence selected from the group consisting of SEQ ID NO: 4, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, and SEQ ID NO:16.
2. A method of treating inflammation comprising administering to a patient in need of such treatment a therapeutically effective amount of an isolated polypeptide of claim 1 .
3. A pharmaceutical composition comprising an isolated polypeptide of claim 1 .
4. A method of treating inflammation comprising administering to a patient in need of such treatment a therapeutically effective amount of the pharmaceutical composition of claim 3 .